We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+7.77%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$950M
AUM Growth
-$195M
Cap. Flow
-$268M
Cap. Flow %
-28.24%
Top 10 Hldgs %
71.59%
Holding
594
New
150
Increased
51
Reduced
81
Closed
305

Top Buys

Rank Stock Value
1
EQNR icon
Equinor
EQNR
+$33.9M
2
APTV icon
Aptiv
APTV
+$21.7M
3
CTRA
Coterra Energy
CTRA
+$19.8M
4
EQT icon
EQT Corp
EQT
+$18.5M
5
OPTU
Optimum Communications Inc
OPTU
+$15.9M

Sector Composition

Rank Sector Weight
1 Energy 14.91%
2 Technology 9.97%
3 Consumer Discretionary 9.75%
4 Communication Services 3.54%
5 Healthcare 3.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TROW icon
126
T. Rowe Price
TROW
$24.3B
$461K 0.05%
+3,592
New +$475K
CTXS
127
DELISTED
Citrix Systems Inc
CTXS
$456K 0.05%
3,310
+538
+19% +$76.9K
LRCX icon
128
Lam Research
LRCX
$383B
$446K 0.05%
13,440
-147,950
-92% -$5.1M
PM icon
129
Philip Morris
PM
$290B
$432K 0.05%
+5,764
New +$445K
CI icon
130
Cigna
CI
$73.6B
$430K 0.05%
2,536
-1,575
-38% -$277K
ELV icon
131
Elevance Health
ELV
$86.2B
$428K 0.05%
1,595
+474
+42% +$128K
BRKR icon
132
Bruker
BRKR
$8.58B
$425K 0.04%
+10,681
New +$445K
PYPL icon
133
PayPal
PYPL
$50.5B
$425K 0.04%
2,159
-68,641
-97% -$12.9M
TXN icon
134
Texas Instruments
TXN
$256B
$421K 0.04%
+2,945
New +$400K
LVGO
135
DELISTED
Livongo Health, Inc. Common Stock
LVGO
$416K 0.04%
+2,971
New +$362K
TENB icon
136
Tenable Holdings
TENB
$4.04B
$414K 0.04%
10,970
-427
-4% -$14.6K
TYL icon
137
Tyler Technologies
TYL
$13B
$413K 0.04%
+1,184
New +$409K
ETSY icon
138
Etsy
ETSY
$7.38B
$412K 0.04%
+3,388
New +$397K
XLNX
139
DELISTED
Xilinx Inc
XLNX
$412K 0.04%
+3,949
New +$405K
A icon
140
Agilent Technologies
A
$42B
$408K 0.04%
+4,043
New +$391K
PXD
141
DELISTED
Pioneer Natural Resource Co.
PXD
$402K 0.04%
+4,672
New +$460K
DXCM icon
142
DexCom
DXCM
$33.1B
$396K 0.04%
+3,840
New +$401K
VRNS icon
143
Varonis Systems
VRNS
$4.87B
$396K 0.04%
+10,296
New +$384K
MED icon
144
Medifast
MED
$135M
$393K 0.04%
+2,388
New +$393K
PEN icon
145
Penumbra
PEN
$12.8B
$393K 0.04%
+2,023
New +$426K
DAVA icon
146
Endava
DAVA
$159M
$392K 0.04%
6,207
ETFC
147
DELISTED
E*Trade Financial Corporation
ETFC
$388K 0.04%
+7,743
New +$404K
PRAH
148
DELISTED
PRA Health Sciences, Inc.
PRAH
$386K 0.04%
3,807
-312
-8% -$31.8K
CLAR icon
149
Clarus
CLAR
$145M
$385K 0.04%
27,256
+5,883
+28% +$73.5K
GIC icon
150
Global Industrial
GIC
$1.52B
$385K 0.04%
16,065
-1,873
-10% -$40.4K

Similar funds

Caxton Associates (New York)'s Q3 2020 Portfolio in Review

As of Q3 2020, Caxton Associates (New York) held 594 positions worth $950M, down 17% from $1.15B the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Caxton Associates (New York) withdrew a net $268M in Q3 2020, closing 305 positions and reducing 81 holdings. Its most notable exit was iShares Silver Trust, an estimated $38.6M position sold in full.

By sector, the portfolio is most concentrated in Energy at 15% of assets, up from 7.5% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Caxton Associates (New York) opened a new position in Equinor worth $30.9M.

  • Caxton Associates (New York)'s largest Q3 2020 buy was Equinor: 2,196,285 shares worth $30.9M.
  • Caxton Associates (New York) added most to Aptiv in Q3 2020, an estimated $21.7M increase.
  • Caxton Associates (New York)'s biggest Q3 2020 reduction was Apple, cutting an estimated $21.7M.
  • Caxton Associates (New York) fully exited iShares Silver Trust in Q3 2020, selling an estimated $38.6M.
  • Caxton Associates (New York)'s ten largest holdings make up 72% of its $950M portfolio in Q3 2020.
  • Caxton Associates (New York) opened 150 new positions and closed 305 in Q3 2020.
  • Caxton Associates (New York)'s portfolio value fell 17% quarter-over-quarter to $950M.

Based on Caxton Associates (New York)'s 13F filing for Q3 2020, filed 16 Nov 2020.